"Transplant Recipients" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Individuals receiving tissues or organs transferred from another individual of the same or different species, or from within the same individual.
| Descriptor ID |
D066027
|
| MeSH Number(s) |
M01.925
|
| Concept/Terms |
Transplant Recipients- Transplant Recipients
- Transplant Recipient
- Recipient, Transplant
- Recipients, Transplant
|
Below are MeSH descriptors whose meaning is more general than "Transplant Recipients".
Below are MeSH descriptors whose meaning is more specific than "Transplant Recipients".
This graph shows the total number of publications written about "Transplant Recipients" by people in this website by year, and whether "Transplant Recipients" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 4 | 1 | 5 |
| 2015 | 3 | 3 | 6 |
| 2016 | 3 | 3 | 6 |
| 2017 | 6 | 3 | 9 |
| 2018 | 2 | 5 | 7 |
| 2019 | 9 | 8 | 17 |
| 2020 | 8 | 8 | 16 |
| 2021 | 4 | 10 | 14 |
| 2022 | 2 | 13 | 15 |
| 2023 | 0 | 7 | 7 |
| 2024 | 1 | 5 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplant Recipients" by people in Profiles.
-
Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum. Clin Infect Dis. 2024 09 26; 79(3):787-794.
-
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients. Blood Adv. 2024 09 10; 8(17):4740-4750.
-
Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion. Transplantation. 2024 Dec 01; 108(12):2336-2350.
-
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2024 05 03; 5:CD003774.
-
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients. Blood Adv. 2024 04 23; 8(8):1880-1892.
-
Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Am Soc Nephrol. 2024 May 01; 35(5):618-629.
-
Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients. J Pediatric Infect Dis Soc. 2024 Feb 28; 13(Supplement_1):S14-S21.
-
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. J Infect Dis. 2024 Feb 14; 229(2):413-421.
-
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clin Infect Dis. 2024 01 25; 78(1):217-226.
-
A modified liver donor risk index for pediatric liver transplant recipients. Liver Transpl. 2024 03 01; 30(3):262-268.